Price Over Earnings Overview: Regeneron Pharmaceuticals
Portfolio Pulse from Benzinga Insights
Regeneron Pharmaceuticals Inc.'s (NASDAQ:REGN) share price is currently at $844.27, after a 0.07% increase. Over the past month, the stock decreased by 0.18%, but in the past year, it went up by 17.75%. The company's P/E ratio of 22.3 is lower than the Biotechnology industry average of 39.1, which could indicate that the stock is undervalued or that shareholders do not expect the stock to perform better in the future.
October 17, 2023 | 2:15 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Regeneron Pharmaceuticals' P/E ratio is lower than the industry average, which could suggest that the stock is undervalued or that it may not perform as well in the future.
Regeneron's P/E ratio is lower than the industry average, which could suggest that the stock is undervalued. However, a lower P/E ratio could also indicate that shareholders do not expect the stock to perform as well in the future. This could potentially impact the stock's short-term performance.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100